Reduced hydrogen peroxide production in neutrophils from patients with diabetes

Diabetes Research and Clinical Practice

Volumn 33, Issue 2, 1996, Pages 119-127

  Inoue, Shoichi ^a   Lan, Yuan ^a   Muran, Jin ^a   Tsuji, Masahiro ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Hokkaido Central Hospital for Social Health Insurance   (Japan)

Author keywords

Colony stimulating factor; Diabetes mellitus; Hydrogen peroxide production; Neutrophils; Phorbol myristate acetate

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROGEN PEROXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; NEUTROPHIL; OXIDATIVE STRESS;

EID: 0030197667     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8227(96)01287-9     Document Type: Article

References (34)

1. [1] Yu, P.H. and Zuo, D.-M. (1993) Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes. Diabetes 42, 594-603.
2. [2] Hiramatsu, K. and Arimori, S. (1988) Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes 37, 832-837.
3. [3] Johnston, R.B. and Kitagawa, S. (1985) Molecular basis for the enhanced respiratory burst of activated macrophages. Fed. Proc., Fed. Am. Soc. Exp. Biol. 44, 2927-2932.
4. [4] Wu, G. and Marliss, E.B. (1993) Enhanced glucose metabolism and respiratory burst in peritoneal macrophages from spontaneously diabetic BB rats. Diabetes 42, 520-529.
5. [5] Bagdade, J.D., Nielson, K.L. and Bulger, R.J. (1972) Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am. J. Med. Sci. 263, 451-456.
6. [6] Mohsenin, V. and Latifpour, J. (1990) Respiratory burst in alveolar macrophages of diabetic rats. J. Appl. Physiol. 68, 2384-2390.
7. [7] Noritake, M., Katsura, Y., Shinomiya, N. et al. (1992) Intracellular hydrogen peroxide production by peripheral phagocytes from diabetic patients. Dissociation between polymorphonuclear leucocytes and monocytes. Clin. Exp. Immunol. 88, 269-274.
8. [8] Tebbs, S.E., Lumbwe, C.M., Tesfaye, S., Gonzalez, A.M. and Wilson, R.M. (1992) The influence of aldose reductase on the oxidative burst in diabetic neutrophils. Diabetes Res. Clin. Pract. 15, 121-129.
9. [9] Tebbs, S.E., Gonzalez, A.M. and Wilson, R.M. (1991) The role of aldose reductase inhibition in diabetic neutrophil phagocytosis and killing. Clin. Exp. Immunol. 84, 482-487.
10. [10] Taniguchi, N. (1992) Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia, and cancer. In: H.E. Spiegel (Ed.), Advances in Clinical Chemistry. Academic Press, San Diego, pp. 1-59.
11. [11] Hostetter, M.K. (1990) Perspectives in diabetes. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes 39, 271-275.
12. [12] Dinerman, J.L., Mehta, J.L., Saldeen, T.G.P. et al. (1990) Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J. Am. Coll. Cardiol. 15. 1559-1563.
13. [13] Schmidt, E.B., Sorensen, P.J., Pedersen, J.O. et al. (1989) The effect of n-3-polyunsaturated fatty acids on lipids, haemostasis, neutrophil and monocyte chemotaxis in insulin-dependent diabetes mellitus. J. Intern. Med. 225, 201-206.
14. [14] Babior, B.M. (1978) Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med. 298, 659-668.
15. [15] Babior, B.M. (1984) The respiratory burst of phagocytes. J. Clin. Invest. 73, 599-601.
16. 2. Studies with normal and cytochalasin B treated cells. J. Clin. Invest. 60, 1266-1279.
17. [17] Shah, S.V., Wallin, J.D. and Eilen, S.D. (1983) Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. J. Clin. Endocrinol. Metab. 57, 402-409.
18. [18] Wykretowicz, A., Wierusz-Wysocka, B., Wysocki, J., Szczepanik, A. and Wysocki, H. (1993) Impairment of the oxygen-dependent microbicidal mechanisms of polymorphonuclear neutrophils in patients with type 2 diabetes is not associated with increased susceptibility to infection. Diabetes Res. Clin. Pract. 19, 195-201.
19. [19] Ornadel, D., Souhami, R.L., Whelan, J. et al. (1994) Doxorubicin and cisplatin with granulocyte colony-stimulating factor as adjuvant chemotherapy for osteosarcoma: a phase II trial of the European Osteosarcoma Intergroup. J. Clin. Oncol. 12, 1842-1848.
20. [20] Kriegel, R.L., Palackdharry, C.S., Padavic, K. et al. (1994) Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer. J. Clin. Oncol. 12, 1251-1258.
21. [21] Greer, I.A., Haddad, N.G., Dawes, J., Johnston, T.A., Johnstone, F.D. and Steel, J.M. (1989) Increased neutrophil activation in diabetic pregnancy and in nonpregnant diabetic women. Obstet. Gynecol. 74, 878-881.
22. [22] Ferrante, A. and Thong, Y.H. (1978) A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique. J. Immunol. Methods 24, 389-393.
23. [23] Yuan, L., Inoue, S., Saito, Y. and Nakajima, O. (1993) An evaluation of the effects of cytokines on intracellular oxidative production in normal neutrophils by flow cytometry. Exp. Cell Res. 209, 375-381.
24. [24] Matsushima, K., Morishita, K., Yoshimura, T. et al. (1988) Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med. 167, 1883-1893.
25. [25] Chervenick, P.A. and LoBuglio, A.F. (1972) Human blood monocytcs: stimulators of granulocyte and mononuclear colony formation in vitro. Science 178, 164-166.
26. [26] Rest, R.F. (1994) Measurement of human neutrophil respiratory burst activity during phagocytosis of bacteria. Methods Enzymol. 236, 119-136.
27. [27] Yuo, A., Kitagawa, S., Ohsaka, A. et al. (1989) Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 74, 2144-2149.
28. [28] Van der Vliet, A., Hu, M.L., O'Neill, C.A., Cross, C.E. and Halliwell, B. (1994) Interactions of human blood plasma with hydrogen peroxide and hypochlorous acid. J. Lab. Clin. Med. 124, 701-707.
29. [29] Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U. and Nishizuka, Y. (1982) Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 257, 7847-7851.
30. [30] Nishizuka, Y. (1986) Studies and perspectives of protein kinase C. Science 233, 305-312.
31. [31] Evans, J.O.M., Mire-Sluis, A.R., Hoffbrand, A.V. and Wickremasinghe, R.G. (1990) Binding of G-CSF. GM-CSF, tumor necrosis factor-α, and γ-interferon to cell surface receptors on human myeloid leukemia cells triggers rapid tyrosine and serine phosphorylation of a 75-kDa protein. Blood 75, 88-95.
32. [32] Evans, S.W., Rennik, D. and Farrar, W.L. (1987) Identification of a signal-transduction pathway shared by haematopoietic growth factors with diverse biological specificity. Biochem. J. 244, 683-691.
33. [33] Elbim, C., Chollet-Martin, S., Bailly, S., Hakim, J. and Gougerot-Pocidalo, M.-A. (1993) Priming of polymorphonuclear neutrophils by tumor necrosis factor α in whole blood: identification of two polymorphonuclear neutrophil subpopulations in response to formyl-peptides. Blood 82, 633-640.
34. [34] Sato, N. and Shimizu, H. (1993) Granulocyte-colony stimulating factor improves an impaired bactericidal function in neutrophils from STZ-induced diabetic rats. Diabetes 42, 470-473.